BioCentury | Jul 26, 2019
Product Development

Takeda's deals paint a picture of a turnaround in action

...or in-licensing deals since the start of 2016, and acquired three companies: Ariad Pharmaceuticals Inc., TiGenix N.V....
...partner press releases, company interviews Partner Technology Deal terms Financial terms Partnership date Cell therapy TiGenix N.V....
...cell therapy Cx601 to treat complex perianal fistulas in Crohn’s disease. In 2018, Takeda acquired TiGenix...
BioCentury | Jun 29, 2019
Finance

All eyes on new modality launches, cancer and rare disease data in 3Q19

...$96.0 $105.0 -9% Stem cells Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) Gained in acquisition of TiGenix N.V....
BioCentury | Mar 9, 2019
Company News

Management tracks: Lundbeck hires first CBO; ICT opens U.S. office

...Madrid, Spain) hired Virginia Gonzalez as CFO. She was head of consolidation and reporting at TiGenix N.V....
BioCentury | Jan 9, 2019
Company News

Management tracks: Tak joins Flagship, Evercore taps Mehrotra

...Therachon AG (Basel, Switzerland) hired Claudia D'Augusta as its first CFO. D'Augusta was CFO at TiGenix N.V....
BioCentury | Oct 19, 2018
Company News

Management tracks: AbbVie, Adverum

...as CMO. She succeeds Jean-Louis Abitbol, who will retire in April. Richard was CMO at TiGenix N.V....
BioCentury | Jun 25, 2018
Company News

Management tracks: Nordic Nanovector, Molecular Partners

...Nanovector ASA (OSE:NANO) hired Eduardo Bravo as CEO, effective July 2. He was CEO at TiGenix N.V....
BioCentury | Jun 13, 2018
Company News

Management tracks: Salk Institute, Galectin

...succeeded by Roger Connor, president of GSK's global manufacturing and supply unit, effective September 1. TiGenix N.V....
...Sebastian Wehle and TiGenix CFO Claudia D’Augusta will be in charge of daily management of TiGenix...
BioCentury | May 11, 2018
Strategy

Takeda hits the gas

...and now approved to treat ALK-positive non-small cell lung cancer (NSCLC). The proposed acquisition of TiGenix N.V....
...Servier, Suresnes, France Shire plc (NASDAQ:SHPG), Dublin, Ireland Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan TiGenix N.V....
BioCentury | Apr 6, 2018
Finance

Fundamentally driven

...heavily treatment-experienced patients with HIV-1 whose infections cannot be treated successfully with existing multidrug-resistant therapies TiGenix N.V....
BioCentury | Apr 6, 2018
Finance

Picking season

...Celgene Corp. (NASDAQ:CELG) Impact Biomedicines Inc. 1/8/18 $1,100.0 $5,900.0 $7,000.0 Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) TiGenix N.V....
Items per page:
1 - 10 of 139
BioCentury | Jul 26, 2019
Product Development

Takeda's deals paint a picture of a turnaround in action

...or in-licensing deals since the start of 2016, and acquired three companies: Ariad Pharmaceuticals Inc., TiGenix N.V....
...partner press releases, company interviews Partner Technology Deal terms Financial terms Partnership date Cell therapy TiGenix N.V....
...cell therapy Cx601 to treat complex perianal fistulas in Crohn’s disease. In 2018, Takeda acquired TiGenix...
BioCentury | Jun 29, 2019
Finance

All eyes on new modality launches, cancer and rare disease data in 3Q19

...$96.0 $105.0 -9% Stem cells Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) Gained in acquisition of TiGenix N.V....
BioCentury | Mar 9, 2019
Company News

Management tracks: Lundbeck hires first CBO; ICT opens U.S. office

...Madrid, Spain) hired Virginia Gonzalez as CFO. She was head of consolidation and reporting at TiGenix N.V....
BioCentury | Jan 9, 2019
Company News

Management tracks: Tak joins Flagship, Evercore taps Mehrotra

...Therachon AG (Basel, Switzerland) hired Claudia D'Augusta as its first CFO. D'Augusta was CFO at TiGenix N.V....
BioCentury | Oct 19, 2018
Company News

Management tracks: AbbVie, Adverum

...as CMO. She succeeds Jean-Louis Abitbol, who will retire in April. Richard was CMO at TiGenix N.V....
BioCentury | Jun 25, 2018
Company News

Management tracks: Nordic Nanovector, Molecular Partners

...Nanovector ASA (OSE:NANO) hired Eduardo Bravo as CEO, effective July 2. He was CEO at TiGenix N.V....
BioCentury | Jun 13, 2018
Company News

Management tracks: Salk Institute, Galectin

...succeeded by Roger Connor, president of GSK's global manufacturing and supply unit, effective September 1. TiGenix N.V....
...Sebastian Wehle and TiGenix CFO Claudia D’Augusta will be in charge of daily management of TiGenix...
BioCentury | May 11, 2018
Strategy

Takeda hits the gas

...and now approved to treat ALK-positive non-small cell lung cancer (NSCLC). The proposed acquisition of TiGenix N.V....
...Servier, Suresnes, France Shire plc (NASDAQ:SHPG), Dublin, Ireland Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan TiGenix N.V....
BioCentury | Apr 6, 2018
Finance

Fundamentally driven

...heavily treatment-experienced patients with HIV-1 whose infections cannot be treated successfully with existing multidrug-resistant therapies TiGenix N.V....
BioCentury | Apr 6, 2018
Finance

Picking season

...Celgene Corp. (NASDAQ:CELG) Impact Biomedicines Inc. 1/8/18 $1,100.0 $5,900.0 $7,000.0 Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) TiGenix N.V....
Items per page:
1 - 10 of 139